Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy
- PMID: 20975743
- PMCID: PMC4178929
- DOI: 10.1038/nrendo.2010.189
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy
Abstract
Glycogen storage disease type I (GSD-I) consists of two subtypes: GSD-Ia, a deficiency in glucose-6-phosphatase-α (G6Pase-α) and GSD-Ib, which is characterized by an absence of a glucose-6-phosphate (G6P) transporter (G6PT). A third disorder, G6Pase-β deficiency, shares similarities with this group of diseases. G6Pase-α and G6Pase-β are G6P hydrolases in the membrane of the endoplasmic reticulum, which depend on G6PT to transport G6P from the cytoplasm into the lumen. A functional complex of G6PT and G6Pase-α maintains interprandial glucose homeostasis, whereas G6PT and G6Pase-β act in conjunction to maintain neutrophil function and homeostasis. Patients with GSD-Ia and those with GSD-Ib exhibit a common metabolic phenotype of disturbed glucose homeostasis that is not evident in patients with G6Pase-β deficiency. Patients with a deficiency in G6PT and those lacking G6Pase-β display a common myeloid phenotype that is not shared by patients with GSD-Ia. Previous studies have shown that neutrophils express the complex of G6PT and G6Pase-β to produce endogenous glucose. Inactivation of either G6PT or G6Pase-β increases neutrophil apoptosis, which underlies, at least in part, neutrophil loss (neutropenia) and dysfunction in GSD-Ib and G6Pase-β deficiency. Dietary and/or granulocyte colony-stimulating factor therapies are available; however, many aspects of the diseases are still poorly understood. This Review will address the etiology of GSD-Ia, GSD-Ib and G6Pase-β deficiency and highlight advances in diagnosis and new treatment approaches, including gene therapy.
Figures
Similar articles
-
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.J Inherit Metab Dis. 2015 May;38(3):511-9. doi: 10.1007/s10545-014-9772-x. Epub 2014 Oct 7. J Inherit Metab Dis. 2015. PMID: 25288127 Review.
-
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.Curr Mol Med. 2002 Mar;2(2):121-43. doi: 10.2174/1566524024605798. Curr Mol Med. 2002. PMID: 11949931 Review.
-
Molecular biology and gene therapy for glycogen storage disease type Ib.J Inherit Metab Dis. 2018 Nov;41(6):1007-1014. doi: 10.1007/s10545-018-0180-5. Epub 2018 Apr 16. J Inherit Metab Dis. 2018. PMID: 29663270 Review.
-
The molecular basis of type 1 glycogen storage diseases.Curr Mol Med. 2001 Mar;1(1):25-44. doi: 10.2174/1566524013364112. Curr Mol Med. 2001. PMID: 11899241 Review.
-
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.Hepatology. 2012 Nov;56(5):1719-29. doi: 10.1002/hep.25717. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22422504 Free PMC article.
Cited by
-
Glycogen Storage Disease Type I and Bone: Clinical and Cellular Characterization.Calcif Tissue Int. 2024 Oct 25. doi: 10.1007/s00223-024-01302-4. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39453459
-
Gene therapy and genome editing for type I glycogen storage diseases.Front Mol Med. 2023 Mar 31;3:1167091. doi: 10.3389/fmmed.2023.1167091. eCollection 2023. Front Mol Med. 2023. PMID: 39086673 Free PMC article. Review.
-
Molecular characterization of positively selected genes contributing aquatic adaptation in marine mammals.Genes Genomics. 2024 Jul;46(7):775-783. doi: 10.1007/s13258-023-01487-2. Epub 2024 May 11. Genes Genomics. 2024. PMID: 38733518
-
A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.BMC Med Genomics. 2024 May 6;17(1):124. doi: 10.1186/s12920-024-01888-6. BMC Med Genomics. 2024. PMID: 38711024 Free PMC article.
-
Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial.Sci Rep. 2024 Apr 15;14(1):8630. doi: 10.1038/s41598-024-59320-z. Sci Rep. 2024. PMID: 38622211 Free PMC article.
References
-
- Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2002;2:121–143. - PubMed
-
- Chou JY, Mansfield BC. In: Membrane Transporter Diseases. Broer S, Wagner CA, editors. Springer; New York: 2003. pp. 191–205. Ch. 13.
-
- Lei K-J, Shelly LL, Pan C-J, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993;262:580–583. - PubMed
-
- Hiraiwa H, Pan C-J, Lin B, Moses SW, Chou JY. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J. Biol. Chem. 1999;274:5532–5536. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources